Summary

The IV equipment market is seeing tremendous growth, owing mostly to developments in healthcare infrastructure and an increasing emphasis on enhancing patient care. Countries such as the United Arab Emirates (UAE), Saudi Arabia, and South Africa are in the vanguard of this expansion, thanks to significant expenditures in healthcare facilities and technology. The prevalence of chronic diseases, combined with an ageing population, has highlighted the need for sophisticated IV equipment to support effective patient care. Infectious infections, maternal health concerns, and non-communicable disorders such as hypertension and diabetes highlight the need for appropriate IV therapy. The Middle East & Africa is a major hub for medical tourism, drawing patients looking for specialised treatments. This flood of patients demands first-rate medical facilities and cutting-edge IV technology. The region's proclivity for adopting cutting-edge medical technologies promotes the use of modern IV equipment with features such as smart pumps and wireless communication. Increased investments in healthcare infrastructure and technology are boosting demand for IV equipment in countries such as South Africa, Nigeria, and Kenya. Partnerships between governments, non-governmental organisations, and private businesses are critical to enhancing healthcare access. These alliances aim to close healthcare gaps and improve IV equipment availability in remote and underprivileged locations. In the region, there is a noticeable tendency towards home-based healthcare options. In order to fulfil this need, IV equipment manufacturers are innovating by creating portable, user-friendly systems that enable effective home-based IV therapy. Economic growth and demographic trends, such as an ageing population in some areas, are pushing up healthcare spending, boosting demand for advanced medical equipment such as IV devices. There is an increasing tendency towards providing solutions tailored to certain regions. Manufacturers are designing IV equipment to meet the Middle East and Africa's particular healthcare needs and infrastructure challenges, driving market innovation.

According to the research report, "Middle East & Africa Intravenous (IV) Equipments Market Outlook, 2028," published by Bonafide Research, the Middle East & Africa Intravenous (IV) Equipments market is anticipated to grow at a 1.70% CAGR by 2023–28. The Middle East & Africa region, particularly the UAE, Saudi Arabia, and South Africa, has seen significant investments in healthcare infrastructure. Modern hospitals, medical centres, and healthcare organisations are springing up everywhere. This infrastructure development fosters an environment conducive to the use of new medical technologies, such as IV equipment. Africa, in particular, has a complex healthcare landscape characterised by a high burden of infectious diseases, maternal health difficulties, and an increasing prevalence of non-communicable diseases. IV equipment is critical in meeting these healthcare needs since it allows for fluid administration, medication delivery, and therapy for a variety of illnesses. The pharmaceutical industry's need for effective drug delivery systems, particularly IV administration, drives demand for high-quality IV equipment. This includes infusion pumps, catheters, and administration sets required for drug and therapy administration. IV equipment manufacturers are investing in technological breakthroughs to create novel and complex devices. This includes smart pumps, wireless connections, and enhanced safety features in IV equipment in response to the Middle East & Africa region's desire for cutting-edge medical gear. Government attempts to improve healthcare infrastructure and accessibility contribute greatly to IV equipment demand. Investments in healthcare systems across the Middle East & Africa increase the demand for innovative medical devices, such as IV equipment, to improve patient care and treatment alternatives.

Based on country report is divided in three major countries United Arab Emirates, Saudi Arabia and South Africa. Among them Saudi Arabia is significant contributor to market growth of Middle East & Africa Intravenous (IV) Equipments market.

The Saudi market places a high priority on quality and conformity to international standards. IV equipment is subjected to rigorous regulatory scrutiny to ensure that it meets stringent quality standards. This dedication to global standards fosters trust and reliability in the gadgets used in healthcare institutions. The country invests heavily in modern healthcare infrastructure. Hospitals and healthcare facilities prioritise the acquisition of cutting-edge IV equipment, contributing to the country's image as a regional hub for high-quality medical services. Saudi Arabia includes digital health solutions, including telemedicine systems and data analytics, into IV equipment. This integration enables remote monitoring of IV medications and enhances treatment efficiency, demonstrating the country's support for digital transformation in healthcare. Saudi Arabia has invested heavily in healthcare infrastructure with the goal of improving the quality of healthcare services and facilities. The country has seen the creation of sophisticated hospitals and healthcare centres outfitted with cutting-edge medical technology, such as IV pumps. As of the government's commitment to enhancing healthcare services, healthcare spending has risen significantly. This increasing expenditure makes it easier to obtain advanced medical equipment such as infusion pumps, catheters, and administration sets, which contributes to the growth of the IV equipment market. Saudi Arabia has implemented a number of steps to improve healthcare services, including improving access to high-quality care. These measures encourage the use of new medical equipment, which helps the IV equipment market develop.

In terms of product market is segmented into IV catheters, infusion pumps, administration sets, securement devices, needless connectors, stopcocks and check valves, drip chambers and others. Infusion pumps products are gaining significant importance in Middle East & Africa IV equipments market.

Chronic diseases such as diabetes, cardiovascular disease, and cancer are on the rise throughout the Middle East and Africa. Infusion pumps are critical in precisely administering drugs and fluids to patients suffering from various illnesses, guaranteeing precise dosages and ongoing therapy. To reduce drug errors and improve patient safety, infusion pumps provide advanced features such as programmable settings, numerous infusion modes, and safety alerts. Hospitals and healthcare facilities throughout the region are progressively implementing these technologies to improve care quality. In the region, there is a growing trend towards home healthcare, driven by an ageing population and a preference for receiving treatment in the comfort of one's own home. Infusion pumps contribute to this by allowing sophisticated therapies to be administered outside of hospital settings. The rising number of surgical procedures, both in hospitals and ambulatory surgical centers, requires efficient and accurate delivery of medications and fluids during and after surgeries. Infusion pumps are integral in these settings to maintain patient stability and recovery.

Based on end user segment market is segmented into hospitals, clinics, home care settings and others. Among them home care settings are predicted to grow at rapid pace in Middle East & Africa. Furthermore based on indication market is bifurcated into cardiovascular disorders & hypertension, pregnancy, diabetes, respiratory diseases, cancer, movement disorders, wound care and other indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV).

Chronic ailments such as diabetes, cardiovascular disease, and respiratory problems are becoming more common in the region. Patients in home care settings can get ongoing and specialised care, including IV treatments, without the need for lengthy hospital visits. Home care environments are a less expensive option than inpatient care, lowering healthcare costs for both patients and healthcare systems. Home IV equipment provides for shorter hospital stays or eliminates the need for frequent hospital visits. Telemedicine and remote monitoring advancements now allow healthcare practitioners to remotely monitor patients undergoing IV treatments at home. This remote supervision improves patient safety while reducing the need for frequent clinic visits. Improvements in infrastructure, including transportation and logistics, are facilitating the delivery of healthcare equipment and services to remote or underserved areas. This allows more patients in these regions to access IV equipment for home-based care. Improved insurance coverage and reimbursement policies for home-based healthcare services and equipment, including IV therapy, encourage patients to opt for home care. This financial support makes home-based treatments more viable and attractive.

Companies Covered in this report:

Becton, Dickinson and Company, B. Braun Melsungen AG, Baxter International Inc., ICU Medical, Inc., Medtronic PLC.

Considered in this report:

• Geography: Middle East & Africa
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:

• Middle East & Africa Intravenous (IV) Equipments market Outlook with its value and forecast along with its segments
• Country-wise Intravenous (IV) Equipments market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:

• United Arab Emirates
• Saudi Arabia
• South Africa

By Product:

• IV Catheters
• Infusion Pumps
• Administration Sets
• Securement Devices
• Needless Connectors
• Stopcocks and Check Valves
• Drip Chambers
• Others

By End User:

• Hospital
• Clinics
• Home Care Settings
• Others

By Indication:

• Cardiovascular Disorders & Hypertension
• Pregnancy
• Diabetes
• Respiratory Diseases
• Cancer
• Movement Disorders
• Wound Care
• Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV)

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience:

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Intravenous (IV) Equipments industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.





***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.

ページTOPに戻る

Table of Contents